Smith & Nephew plc は1株あたり年間配当金が 0.374 で、利回りは 0.00% です。配当金は 半年ごと に支払われ、最後の除息日は Oct 3, 2025 でした。
配当利回り
年間配当
除権日
0.00%
$0.374
Oct 3, 2025
支払い頻度
支払率
半年ごと
0.00%
配当履歴
除権日
現金額
記録日
支払日
Oct 3, 2025
$0.30
Oct 3, 2025
Nov 7, 2025
Mar 28, 2025
$0.462
Mar 28, 2025
May 28, 2025
Oct 4, 2024
$0.288
Oct 4, 2024
Nov 8, 2024
Apr 1, 2024
$0.462
Apr 2, 2024
May 22, 2024
Oct 5, 2023
$0.288
Oct 6, 2023
Nov 1, 2023
Mar 30, 2023
$0.462
Mar 31, 2023
May 17, 2023
配当チャート
SNN 配当
SNN 配当成長率(年間比)
Follow-Up Questions
Smith & Nephew plcの現在の配当金と年間配当金はいくらですか?
Smith & Nephew plcの配当性向は何ですか?
SNNの配当落ち日はいつですか?
Smith & Nephew plcはどのくらいの頻度で配当金を支払いますか?
主要データ
前終値
$35.3
始値
$35.58
当日レンジ
$35.45 - $35.83
52週レンジ
$23.91 - $38.79
取引高
689.3K
平均取引高
719.5K
1株当たり利益(TTM)
1.12
配当利回り
--
時価総額
$15.0B
Smith & Nephew SNATS, Inc.とは何ですか?
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. The company is headquartered in Watford, Hertfordshire and currently employs 17,000 full-time employees. The firm is engaged in developing, manufacturing, marketing, and selling medical devices and services. The company is focused on the repair, regeneration, and replacement of soft and hard tissue. The firm's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.